Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.

Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Morel-Fourrier B, Brouet JC, Alarcon-Segovia D, Galanaud P, Emilie D.

J Exp Med. 1995 Mar 1;181(3):839-44.

2.

Treatment of rheumatoid arthritis with anti CD4 monoclonal antibody. Open study of 25 patients with the B-F5 clone.

Wendling D, Racadot E, Morel-Fourrier B, Wijdenes J.

Clin Rheumatol. 1992 Dec;11(4):542-7.

PMID:
1486748
3.

Monoclonal antibodies in human organ transplantation and auto-immune diseases.

Wijdenes J, Roy C, Morel-Fourrier B, Racadot E.

Therapie. 1992 Jul-Aug;47(4):283-7. Review.

PMID:
1494788
4.

Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies.

Wijdenes J, Clement C, Klein B, Morel-Fourrier B, Vita N, Ferrara P, Peters A.

Mol Immunol. 1991 Nov;28(11):1183-92.

PMID:
1720501
5.

Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis.

Wendling D, Wijdenes J, Racadot E, Morel-Fourrier B.

J Rheumatol. 1991 Mar;18(3):325-7.

PMID:
1713269
6.

Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10)

Hervé P, Wijdenes J, Bergerat JP, Bordigoni P, Milpied N, Cahn JY, Clément C, Béliard R, Morel-Fourrier B, Racadot E, et al.

Blood. 1990 Feb 15;75(4):1017-23.

Supplemental Content

Loading ...
Support Center